SCHEMBL4884951

SCHEMBL4884951

CCCCC(N)c1nc2ccccc2s1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 1/20 0.55
HPGD P15428 2/20 0.45
ALOX5 P09917 1/20 0.45
UBE2T Q9NPD8 1/20 0.42
ASIC3 Q9UHC3 1/20 0.42
NPC1 O15118 5/20 0.42
RAB9A P51151 5/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
GAA P10253 3/20 0.42
CASR P41180 1/20 0.42
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
ALDH1A1 P00352 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 2/20 0.41
NFKB1 P19838 1/20 0.41
STAT1 P42224 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22919771 0.83 LOXL2 (0.65) LOXL2HPGDALOX5UBE2TASIC3
SCHEMBL3522245 0.79 LOXL2 (0.68) LOXL2HPGDALOX5UBE2TASIC3
SCHEMBL7735961 0.79 LOXL2 (0.51) LOXL2HPGDALOX5UBE2TASIC3
SCHEMBL8319172 0.78 LOXL2 (0.62) LOXL2HPGDALOX5UBE2TASIC3
SCHEMBL21291322 0.78 LOXL2 (0.50) LOXL2HPGDALOX5UBE2TASIC3
SCHEMBL3030726 0.78 LOXL2 (0.50) LOXL2HPGDALOX5UBE2TASIC3
SCHEMBL18924692 0.78 LOXL2 (0.61) LOXL2HPGDALOX5UBE2TASIC3
SCHEMBL21013849 0.78 LOXL2 (0.61) LOXL2HPGDALOX5UBE2TASIC3
SCHEMBL27940631 0.78 LOXL2 (0.50) LOXL2HPGDALOX5UBE2TASIC3
SCHEMBL13982831 0.78 LOXL2 (0.57) LOXL2HPGDALOX5UBE2TASIC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7384966-B2 2-arylbenzothiazole derivatives PHARMINXO LIMITED (GB) 2008-06-10 US disclosed
US-20060063816-A1 2-Arylbenzothiazole derivatives STEVENS MALCOLM F G 2006-03-23 US disclosed
US-6197969-B1 REACTING METAL SALT OF 2-AMINOTHIOPHENOL WITH AN AMINO ACID-N-CARBOXYLIC ANHYDRIDE; CYCLIZATION IN ACID IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2001-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063816-A1 2-Arylbenzothiazole derivatives CX3CR1, HCN2, CYBB LOXL2 204/4885HPGD 854/4885ALOX5 1504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.